Stay updated on Sasanlimab in Advanced Malignancies Clinical Trial
Sign up to get notified when there's something new on the Sasanlimab in Advanced Malignancies Clinical Trial page.

Latest updates to the Sasanlimab in Advanced Malignancies Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedUpdate announces version v3.2.0 and adds a government funding and operating status notice, replacing the previous v3.1.0.SummaryDifference2%
- Check16 days agoChange DetectedUpdated version from v3.0.2 to v3.1.0, indicating a new release. No other content changes were detected.SummaryDifference0.1%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed, with no substantive changes to core content.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.1%
- Check46 days agoChange DetectedThe web page has undergone significant updates, including the addition of detailed location information for various regions in Russia, South Korea, and Ukraine, as well as new publications related to non-small cell lung carcinoma. Some previously listed locations and terms have been removed.SummaryDifference18%
- Check60 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to Sasanlimab in Advanced Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sasanlimab in Advanced Malignancies Clinical Trial page.